| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd4789de99f66ceb304899846ff5f4c3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 |
| filingDate |
2019-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6227fe88da9df82013392129de3c121c |
| publicationDate |
2020-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2720455-C1 |
| titleOfInvention |
Radiosensitizer |
| abstract |
FIELD: medicine.SUBSTANCE: invention refers to medicine, particularly to oncology, namely to using lithium ascorbate as a radiosensitizer. Agent represents lithium ascorbate with formula LiCHO.EFFECT: wider range of products having radiation-sensitizing activity.1 cl, 1 tbl |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2752829-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2763884-C1 |
| priorityDate |
2019-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |